Advanced search
Publication Cover
Substance Use & Misuse Volume 59, 2024 - Issue 9
Submit an article Journal homepage
71
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Investigation of Simulated Adherence in Long-Term Buprenorphine/Naloxone Treatment Patients

Nusrat Rahmana Bentley Health Thought Leadership Network, Bentley University, Waltham, Massachusetts, USA;b Department of Natural and Applied Sciences, Bentley University, Waltham, Massachusetts, USA;c Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts, USAView further author information
,
Abhilash Janardhananc Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts, USAView further author information
,
Sahil Shikalgarc Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts, USAView further author information
,
Mohammad Aslam Pirkhanc Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts, USAView further author information
,
James Cannerd Gravity Diagnostics, Covington, Kentucky, USAView further author information
,
Christopher Skipwitha Bentley Health Thought Leadership Network, Bentley University, Waltham, Massachusetts, USA;b Department of Natural and Applied Sciences, Bentley University, Waltham, Massachusetts, USAView further author information
&
Md. Noor-E-Alamc Department of Mechanical and Industrial Engineering, Northeastern University, Boston, Massachusetts, USACorrespondence[email protected]
View further author information
 show all
Pages 1275-1279 | Published online: 10 Nov 2023

Reference

  • Accurso, A. J., Lee, J. D., & McNeely, J. (2017). High prevalence of urine tampering in an office-based opioid treatment practice detected by evaluating the norbuprenorphine to buprenorphine ratio. Journal of Substance Abuse Treatment, 83, 62–67. https://doi.org/10.1016/j.jsat.2017.10.002
  • Elkader, A., & Sproule, B. (2005). Buprenorphine: Clinical pharmacokinetics in the treatment of opioid dependence. Clinical Pharmacokinetics, 44(7), 661–680. https://doi.org/10.2165/00003088-200544070-00001
  • Heidbreder, C., Fudala, P. J., & Greenwald, M. K. (2023). History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder. Drug and Alcohol Dependence Reports, 6, 100133. https://doi.org/10.1016/j.dadr.2023.100133
  • Holt, S. R., Donroe, J. H., Cavallo, D. A., & Tetrault, J. M. (2019). Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder. Drug and Alcohol Dependence, 205, 107174–107601. https://doi.org/10.1016/j.drugalcdep.2019.107601
  • Hull, M. J., Bierer, M. F., Griggs, D. A., Long, W. H., Nixon, A. L., & Flood, J. G. (2008). Urinary buprenorphine concentrations in patients treated with Suboxone®; as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay. Journal of Analytical Toxicology, 32(7), 516–521. https://doi.org/10.1093/jat/32.7.516
  • Lee, D., Bazydlo, L. A., Reisfield, G. M., & Goldberger, B. A. (2015). Urine spiking in a pain medicine clinic: An attempt to simulate adherence. Pain Medicine, 16(7), 1449–1451. https://doi.org/10.1111/pme.12663
  • McMillin, G. A., Davis, R., Carlisle, H., Clark, C., Marin, S. J., & Moody, D. E. (2012). Patterns of free (Unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography–tandem mass Spectrometry. Journal of Analytical Toxicology, 36(2), 81–87. https://doi.org/10.1093/jat/bkr020
  • Pizzicato, L. N., Hom, J. K., Sun, M., Johnson, C. C., & Viner, K. M. (2020). Adherence to buprenorphine: An analysis of prescription drug monitoring program data. Drug and Alcohol Dependence, 216, 108317. https://doi.org/10.1016/j.drugalcdep.2020.108317
  • Suzuki, J., Zinser, J., Issa, M., & Rodriguez, C. (2017). Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment. Substance Abuse, 38(4), 504–507. https://doi.org/10.1080/08897077.2017.1356796
  • Tkacz, J., Severt, J., Cacciola, J., & Ruetsch, C. (2012). Compliance with buprenorphine medication-assisted treatment and relapse to opioid use. The American Journal on Addictions, 21(1), 55–62. https://doi.org/10.1111/j.1521-0391.2011.00186.x
  • Warrington, J. S., Warrington, G. S., Francis-Fath, S., & Brooklyn, J. (2020). Urinary buprenorphine, norbuprenorphine and naloxone concentrations and ratios: Review and potential clinical implications. Journal of Addiction Medicine, 14(6), e344–e349. https://doi.org/10.1097/ADM.0000000000000676
  • Yokell, M. A., D Zaller, N., C Green, T., & D Rich, J. (2011). Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: An international review. Current Drug Abuse Reviews, 4(1), 28–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.